Skip to main content
. 2010 May;51(5):1057–1062. doi: 10.1194/jlr.M002915

TABLE 5.

Treatment-emergent adverse events (>10% Mipomersen)

Event Placebo (n = 11) Mipomersen (n = 10)
Injection site reaction 8 (73) 10 (100)
Influenza-like illness 2 (18) 7 (70)
Influenza 1 (9) 3 (30)
Nasopharyngitis 4 (36) 3 (30)
Headache 6 (55) 3 (30)
Fatigue 5 (46) 2 (20)
Myalgia 1 (9) 2 (20)
Back pain 0 (0) 2 (20)
Upper abdominal pain 0 (0) 2 (20)
Nausea 0 (0) 2 (20)
Cough 0 (0) 2 (20)

The numbers in parentheses are percentages.